A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts

NCT03259620 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

491

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous Common Warts

Interventions

DRUG: CLS006
DRUG: CLS006 Vehicle

Sponsor

Maruho Co., Ltd.